FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to an infusion solution for total blood volume replacement, hydro-electrolytic rebalancing, trace recovery, and hematopoiesis process normalisation. The declared solution contains sodium, potassium, calcium, magnesium, chloride and acetate ions with water, and in addition it contains cobalt, zinc and manganese ions in the following proportions, mmole: Na+ -140; K+ - 4; Ca++ - 2,5; Mg++ - 1; Co++ - 0.0006; Zn++ - 0.022; Mn++ - 0.004; CI- - 111; CH3COO- - 40; and water for injections up to 1 l.
EFFECT: solution is balanced in relation to an ionic composition of human blood plasma and effects on erythropoiesis stimulation.
8 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INFUSION SOLUTION | 2019 |
|
RU2708389C1 |
| MULTICOMPONENT INFUSION SOLUTION OF ELECTROLYTES IN COMBINATION WITH BIOLOGICALLY ACTIVE COMPONENTS FOR INTRAVENOUS ADMINISTRATION | 2022 |
|
RU2796724C1 |
| ISOTONIC INFUSION SOLUTION | 2020 |
|
RU2744331C1 |
| MEDICINAL AGENT FOR NORMALIZATION OF ACID-ALKALINE EQUILIBRIUM AND AQUEOUS-ELECTROLYTE BALANCE DISTURBANCE | 1995 |
|
RU2056837C1 |
| PREPARATION OF HEMODYNAMIC ACTION WITH THE FUNCTION FOR NORMALIZATION OF ACID-BASE BALANCE AND ELECTROLYTE ONE | 2000 |
|
RU2185173C2 |
| BALANCED INFUSION SOLUTION | 2014 |
|
RU2549448C1 |
| METHOD OF TREATING HEMORRHAGIC SHOCK OF I, II AND III DEGREE OF SEVERITY | 2011 |
|
RU2482840C2 |
| METHOD FOR INTRAOPERATIVE AND EARLY POSTOPERATIVE INFUSION THERAPY | 2011 |
|
RU2523555C2 |
| ARTIFICIAL PLASMA EXTENDER | 2014 |
|
RU2582219C2 |
| METHOD OF DETERMINING OSMOLARITY OF ELECTROLYTIC INFUSION SOLUTIONS | 2008 |
|
RU2357244C1 |
